Expediente |
2024/S 000-024256 |
Organismo |
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) |
Código Postal |
|
Fecha de publicación |
02/08/2024 |
Section one: Contracting authoritySection I: Contracting authorityone.1) Name and addressesI.1) Name and addressesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
Contactnadia Crockett
EmailNadia.crockett@nhs.scot
CountryUnited Kingdom
NUTS codeUKM - Scotland
Internet address(es)Main addresshttp://www.nss.nhs.scot/browse/procurement-and-logistics
Buyer's addresshttps://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
one.2) Information about joint procurementI.2) Information about joint procurementThe contract is awarded by a central purchasing body
one.3) CommunicationI.3) CommunicationThe procurement documents are available for unrestricted and full direct access, free of charge, at
https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html
one.4) Type of the contracting authorityI.4) Type of the contracting authorityBody governed by public law
one.5) Main activityI.5) Main activityHealth
Section two: ObjectSection II: Objecttwo.1) Scope of the procurementII.1) Scope of the procurementtwo.1.1) TitleII.1.1) TitleNP39724 Generic and Biosimilar Cancer Medicines
Reference numberNP39724
two.1.2) Main CPV codeII.1.2) Main CPV code33600000 - Pharmaceutical products
two.1.3) Type of contractII.1.3) Type of contractSupplies
two.1.4) Short descriptionII.1.4) Short descriptionSupply of Generic and Biosimilar Cancer Medicines to NHS Scotland.
two.1.5) Estimated total valueII.1.5) Estimated total valueValue excluding VAT: £57,386,767
two.1.6) Information about lotsII.1.6) Information about lotsThis contract is divided into lots: Yes
Tenders may be submitted for all lots
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleOxaliplatin Vial Solution
Lot No23
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Oxaliplatin Vial Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £157,351
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitlePaclitaxel Concentrate For Intravenous Infusion
Lot No24
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £442,323
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleTopotecan Capsules
Lot No29
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Topotecan Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £53,280
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleOctreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare)
Lot No35
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants]. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £849,897
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleBendamustine Powder For Solution For Infusion
Lot No1
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £123,054
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleCapecitabine Tablets
Lot No2
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Capecitabine Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £723,873
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleCarboplatin Injections
Lot No3
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Carboplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework . Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £676,953
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleCisplatin Injections
Lot No4
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Cisplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £1,424,495
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleCyclophosphamide Injection, Powder For Reconstitution
Lot No5
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £304,922
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleCytarabine Injections
Lot No6
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Cytarabine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £79,599
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleDacarbazine Injections
Lot No7
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Dacarbazine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £257,544
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleDisodium Folinate Injections
Lot No8
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Disodium Folinate Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £291,108
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleDocetaxel Concentrate For Solution For Infusion
Lot No9
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £263,871
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleDoxorubicin Solution For Injection Vials
Lot No10
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Doxorubicin Solution For Injection Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £64,886
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleFluorouracil 25MG/ML Injections
Lot No11
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Fluorouracil Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £61,696
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleFluorouracil 50MG/ML Injections
Lot No12
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Fluorouracil 50MG/ML Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £299,132
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleGemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
Lot No13
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £117,507
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleGemcitabine 100MG/ML Concentrate For Solution For Infusion Vials
Lot No14
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £49,716
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleGemcitabine Powder For Solution For Infusion Vials
Lot No15
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £240,009
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleIdarubicin Hydrochloride Injection Powder For Reconstitution
Lot No16
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Idarubicin Hydrochloride Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £105,985
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleIfosfamide Injection Powder For Reconstitution
Lot No17
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £1,765,159
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleIrinotecan Hydrochloride Injections
Lot No18
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Irinotecan Hydrochloride Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £244,363
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleLanreotide Injection Prefilled Syringes (unbundled - without homecare)
Lot No19
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Lanreotide Injection Prefilled Syringes (unbundled - without homecare). The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £9,053,054
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleLanreotide Injection Prefilled Syringes (bundled - with homecare)
Lot No20
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Lanreotide Injection Prefilled Syringes (bundled - with homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £9,053,054
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleMethotrexate Without Preservatives Injections
Lot No21
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £325,008
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleMethotrexate Oral Solution
Lot No22
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Methotrexate Oral Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £39,204
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleRange of Generic Cancer Medicines (single supplier)
Lot No41
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Range of Generic Cancer Medicines to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £20,718,149
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleIdarubicin Hydrochloride Solution For Infusion Vials
Lot No40
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Idarubicin Hydrochloride Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £97,179
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleRange Generic & Biosimilar Cancer Medicines (unranked)
Lot No39
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Range of Generic & Biosimilar Medicines to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per product line to a maximum of six (6) suppliers. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £8,766,044
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleDasatinib Tablets
Lot No38
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Dasatinib Tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £467,223
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleEtoposide Injections
Lot No37
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Etoposide Injection to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £209,908
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleOctreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare)
Lot No36
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants]. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £643,483
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitlePemetrexed (25Mg/Ml) Solution For Infusion Vials
Lot No34
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £489,380
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitlePemetrexed Powder For Solution For Infusion Vials
Lot No33
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Pemetrexed Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £49,952
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleFilgrastim Pre-Filled Syringes
Lot No32
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Filgrastim Pre-Filled Syringes to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £187,944
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleOctreotide Injections
Lot No31
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Octreotide Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £108,340
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleTopotecan Concentrate For Solution For Infusion
Lot No30
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Topotecan Concentrate For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £6,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleAprepitant Capsules
Lot No28
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Aprepitant Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £175,100
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleVinorelbine Injections
Lot No27
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Vinorelbine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £39,900
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleVincristine Without Preservatives Injection
Lot No26
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £112,228
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleTemozolomide Capsules
Lot No25
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UKM - Scotland
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Temozolomide Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £108,280
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitlePaclitaxel Albumin Vials
Lot No43
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UK - United Kingdom
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Paclitaxel Albumin Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier per product line. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: Logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £3,700,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-two (22) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional informationII.2.14) Additional informationThis Lot will have a framework start date of 1 April 2025.
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleBosutinib Tablets
Lot No42
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UK - United Kingdom
Main site or place of performanceAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurementII.2.4) Description of the procurementSupply of Bosutinib tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
two.2.5) Award criteriaII.2.5) Award criteriaQuality criterion - Name: logistics / Weighting: 5
Price - Weighting: 95
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £3,500,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemDuration in months24
This contract is subject to renewalYes
Description of renewalsThis framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-two (22) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: No
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional informationII.2.14) Additional informationThis Lot will have a framework start date of 1 April 2025.
Section three. Legal, economic, financial and technical informationSection III. Legal, economic, financial and technical informationthree.1) Conditions for participationIII.1) Conditions for participationthree.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registersIII.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registersList and brief description of conditionsEconomic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
three.1.3) Technical and professional abilityIII.1.3) Technical and professional abilityList and brief description of selection criteria(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender bar the following medicines; Bosutinib, Eribulin, Paclitaxel Albumin. For these medicines, potential framework participants must be able to demonstrate the existence of a valid and current UK marketing authorization (PL, PLGB, or PLPI) that has been approved by the MHRA by the date of commencement of the framework agreement.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum level(s) of standards possibly required(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender (bar the following medicines; Bosutinib, Eribulin, Paclitaxel Albumin which must be demonstrated by the date of commencement of the framework agreement) should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.
(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.
(c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products.
(d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder?s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.
Section four. ProcedureSection IV. Procedurefour.1) DescriptionIV.1) Descriptionfour.1.1) Type of procedureIV.1.1) Type of procedureOpen procedure
four.1.3) Information about a framework agreement or a dynamic purchasing systemIV.1.3) Information about a framework agreement or a dynamic purchasing systemThe procurement involves the establishment of a framework agreement
Framework agreement with several operators
four.1.8) Information about the Government Procurement Agreement (GPA)IV.1.8) Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative informationIV.2) Administrative informationfour.2.2) Time limit for receipt of tenders or requests to participateIV.2.2) Time limit for receipt of tenders or requests to participateDate2 September 2024
Local time12:00pm
four.2.4) Languages in which tenders or requests to participate may be submittedIV.2.4) Languages in which tenders or requests to participate may be submittedEnglish
four.2.7) Conditions for opening of tendersIV.2.7) Conditions for opening of tendersDate2 September 2024
Local time12:00pm
Section six. Complementary informationSection VI. Complementary informationsix.1) Information about recurrenceVI.1) Information about recurrenceThis is a recurrent procurement: No
six.2) Information about electronic workflowsVI.2) Information about electronic workflowsElectronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
six.3) Additional informationVI.3) Additional informationThe estimated value(s) referred to in Section II.1.5 and within all Lots covers the 24 month contract duration and the 24 month extension period of the framework agreement.
The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 27238. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343
A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363
Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/
A summary of the expected community benefits has been provided as follows:
It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework.
Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved.
Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland?s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits.
(SC Ref:772664)
six.4) Procedures for reviewVI.4) Procedures for reviewsix.4.1) Review bodyVI.4.1) Review bodySheriff Court House
27 Chambers Street
Edinburgh
EH1 1LB
Emailedinburgh@scotcourts.gov.uk
Telephone+44 1312252525
CountryUnited Kingdom
Internet addresshttps://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts
six.4.3) Review procedureVI.4.3) Review procedurePrecise information on deadline(s) for review proceduresThe Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ?standstill period? of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Back to top
*Fecha Pub.: 02/08/2024
*Fuente ext: UK
*Enlace ext: https://www.find-tender.service.gov.uk/Notice/024256-2024